[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempus AI Cl A (TEM)

Tempus AI Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Tempus AI's Path to Profitability Reaches Its First Real Checkpoint

Tempus AI (NASDAQ: TEM) reports first-quarter 2026 earnings tomorrow, May 5, after market close, with analysts expecting the precision medicine company to post a loss of $0.47 per share—a significant deterioration from the prior quarter's $0.29 loss. The central question: can management demonstrate progress toward profitability while maintaining the 60%+ revenue growth that has defined the company's trajectory, or will widening losses and a deteriorating technical picture signal deeper operational challenges ahead?

Tempus AI is a leading precision medicine company that leverages artificial intelligence and machine learning to analyze clinical and molecular data—primarily for oncology, but increasingly in cardiology and radiology—with a mission to...

Fundamentals

See More
  • Market Capitalization, $K 9,977,378
  • Shares Outstanding, K 178,774
  • Annual Sales, $ 1,272 M
  • Annual Income, $ -245,030 K
  • EBIT $ -253 M
  • EBITDA $ -146 M
  • 60-Month Beta 3.99
  • Price/Sales 7.73
  • Price/Cash Flow N/A
  • Price/Book 19.96

Options Overview Details

View History
  • Implied Volatility 80.00% (+0.87%)
  • Historical Volatility 76.05%
  • IV Percentile 65%
  • IV Rank 49.98%
  • IV High 99.37% on 05/06/25
  • IV Low 60.65% on 12/10/25
  • Expected Move (DTE 3) 4.44 (8.16%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 8,859
  • Volume Avg (30-Day) 21,170
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 297,664
  • Open Int (30-Day) 288,800
  • Expected Range 49.91 to 58.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.47
  • Number of Estimates 5
  • High Estimate $-0.38
  • Low Estimate $-0.58
  • Prior Year $-0.29
  • Growth Rate Est. (year over year) -62.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.41 +27.26%
on 04/10/26
58.04 -7.01%
on 04/16/26
+6.58 (+13.88%)
since 04/02/26
3-Month
41.73 +29.33%
on 03/30/26
62.00 -12.95%
on 02/20/26
+1.53 (+2.92%)
since 02/05/26
52-Week
41.73 +29.33%
on 03/30/26
104.32 -48.26%
on 10/09/25
-0.10 (-0.18%)
since 05/05/25

Most Recent Stories

More News
Tempus AI's Path to Profitability Reaches Its First Real Checkpoint

Barchart Research What to Expect from TEM Earnings TEM Generated May 4, 2026 Current Price $55.81 EPS Estimate $$-0.47 Consensus Rating Moderate Buy Average Move 7.47% Tempus AI's Path to Profitability...

TEM : 54.38 (-2.56%)
Tempus to Host Inaugural Investor Day on May 29, 2026

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that the company will host an Investor Day on Friday, May 29, 2026. The event...

TEM : 54.38 (-2.56%)
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Tempus AI, Inc. (NASDAQ: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence, today announced it has been named to TIME’s 10 Most...

TEM : 54.38 (-2.56%)
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and the Keck School of Medicine of USC and Keck Medicine of USC, today announced a multi-faceted...

TEM : 54.38 (-2.56%)
Tempus to Report First Quarter 2026 Financial Results on May 5

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it will report financial results for the first quarter ended March 31, 2026...

TEM : 54.38 (-2.56%)
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta Biosciences, a precision oncology company developing novel diagnostic solutions...

TEM : 54.38 (-2.56%)
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts—including one oral presentation—for the...

TEM : 54.38 (-2.56%)
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of an automated clinical update service designed to support guideline-concordant...

TEM : 54.38 (-2.56%)
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced an expanded, multi-year collaboration with Gilead Sciences, Inc. (Nasdaq: GILD)...

GILD : 132.78 (+0.07%)
TEM : 54.38 (-2.56%)
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will present at the 25th Annual Needham Virtual Healthcare Conference, taking place April 13-16....

TEM : 54.38 (-2.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery,...

See More

Key Turning Points

3rd Resistance Point 58.84
2nd Resistance Point 57.55
1st Resistance Point 56.68
Last Price 54.38
1st Support Level 54.52
2nd Support Level 53.23
3rd Support Level 52.36

See More

52-Week High 104.32
Fibonacci 61.8% 80.41
Fibonacci 50% 73.03
Fibonacci 38.2% 65.64
Last Price 54.38
52-Week Low 41.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.